Clinical Trial Update: Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a stem cell transplant using peripheral and cord blood stem cells for severe aplastic anemia and myelodysplastic syndrome with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Myelodysplastic Syndrome

Drugs mentioned

• Peripheral blood stem cells and cord blood stem cells transplant

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) | Phase 2 | Status: COMPLETED | Results posted: 2020-07-31